← Back to All Filings

Viatris Inc (VTRS) Director Vests 24,835 Shares

Low SignificanceMarch 10, 2026 at 7:18:02 PM EDT

Viatris Inc

$VTRS4CIK: 0001792044

Subscribe to track VTRS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Viatris Inc (VTRS) Director Vests 24,835 Shares

Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low

Insider: MARK RICHARD A Title: Director | Relationship: Director

Transaction: • Type: Grant/Vesting • Shares: 24,835 • Price: $0.00 • Value: $0.00 • Owned After: 116,145

Key Insight: Routine vesting of Restricted Stock Units (RSUs) and Dividend Equivalent Units. No open market activity.

Market Context: Transaction represents <0.01% of the $17.19B market cap company.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Viatris Inc (VTRS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Routine vesting of stock awards and new RSU grants; no open market activity.
  • Market Impact: Neutral - This is standard director compensation.

Company Information

FieldValue
CompanyViatris Inc
Ticker SymbolVTRS
CIK0001792044
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameMARK RICHARD A
CIK0001676105
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-06
Transaction CodeM (Exercise/Vesting)
Security TypeCommon Stock
Shares Involved24,835
Price Per Share$0.00
Total Value$0.00
Shares Owned After116,145
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0.00 (Compensation)
% of Market Cap0.00%
Shares Transacted24,835
% of Shares Outstanding0.002%
Post-Transaction Ownership116,145 shares (0.01% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market cap of $17.19 billion, this compensation event is immaterial to the broader capital structure.
  • Ownership Concentration: The insider holds approximately 0.01% of the 1.15 billion shares outstanding.
  • Dilution Impact: Negligible. The shares represent roughly 0.002% of the total float.
  • Transaction Significance: The transaction falls well below the 0.1% threshold for significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a non-discretionary transaction related to the vesting of previously awarded equity and a new annual grant. It does not reflect insider sentiment regarding the stock price.

Volume & Sentiment

  • Expected Volume Impact: None.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Details: The reporting person acquired 23,660 shares via RSU vesting and 1,175 shares via Dividend Equivalent Units (DEUs).
  • New Grants: The filing also reports a new grant of 15,890 RSUs which will vest on March 6, 2027.
  • Price: All transactions were at $0.00 as part of an incentive plan.
Topics:#SECFiling#VTRS#Viatris#Form4#InsiderTrading#StockAlert#Pharma#Compensation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.